| |
Case 1 M |
Case 2 F |
Case 3 M |
Case 4 M |
Case 5 M |
| Presenting complaint |
Reduced vision |
Glare / halos |
Reduced vision |
Reduced vision |
Reduced vision |
| Time of presentation after surgery |
8 years |
7 years |
7 years |
7 years |
8 years |
| Significant history |
Vogt-Koyanagi-Harada disease |
Diabetes mellitus |
Myopia |
Acute Anterior Uveitis |
Diabetes mellitus |
| PCIOL Type |
AcrySof MA60AC |
AcrySof MA60AC |
AcrySof MA60AC |
Tecnis ZA9003 (AMO) |
AcrySof MA60AC |
| OVD use at the time of Surgery |
Healon-GV |
Healon-GV |
Healon-GV |
Healon-GV |
Healon -GV |
| Clinical sign |
Retrolenticular fluid |
Retrolenticular fluid |
Retrolenticular fluid |
Retrolenticular fluid, shallow anterior chamber |
Retrolenticular fluid, shallow anterior chamber |
| BCVA (pre- treatment)
BCVA (post- treatment) |
6/18
6/6 |
6/9
6/6 |
6/12
6/9 |
6/12
6/6 |
6/12
6/9 |
| Myopic shift(pre- treatment)
Refractive status (post- treatment) |
-1.75DS
Plano |
Plano
Plano |
-1.0DS
-0.50DS |
-1.50DS
-0.50DS |
-1.25DS
-1.00DS |
| Posterior capsular distension(μm) |
1180 |
760 |
1380 |
1600 |
940 |
| Axial length |
22.63mm |
22.47mm |
26.10mm |
23.59mm |
22.10mm |
| White to white diameter |
11.6 mm |
11.7mm |
11.8 mm |
11.6 mm |
11.6 mm |
| AC depth (pre-treatment)
AC depth (post-treatment) |
3400 μ
3450 μ |
4060 μ
4080 μ |
4310 μ
4420 μ |
2620 μ
3520 μ |
4190 μ
4340 μ |
| Residual lens matter/liquefied milky fluid |
Yes |
Yes |
Yes |
Yes |
Yes |
| Anterior capsular opacification |
Yes |
no |
no |
Yes |
no |
| Abbreviations: M: male; F: female; PCIOL: posterior chamber intraocular lens; OVD: ophthalmic viscoelastic device; BCVA: best corrected visual acuity; AC: anterior chamber |
